Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v1-EN
Language French English
Date Updated 2017-06-13 2017-06-06
Drug Identification Number 02448858 02448858
Brand name SOMAVERT SOMAVERT
Common or Proper name Somavert Somavert
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients PEGVISOMANT PEGVISOMANT
Strength(s) 30MG 30MG
Dosage form(s) KIT POWDER FOR SOLUTION KIT POWDER FOR SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 1 x 1mL pre filled syringe 1 x 1mL pre filled syringe
ATC code H01AX H01AX
ATC description ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2017-06-05 2017-06-05
Estimated end date 2017-06-12 2017-06-16
Actual end date 2017-06-12
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Resolved June 12, 2017. Please note that Somavert is fully available for the following strengths: · 10mg SFDPO 1x1ml · 15mg SFDPO 1x1ml · 20mg SFDPO 1x1ml · 25mg SFDPO 1x1ml Please note that Somavert is fully available for the following strengths: · 10mg SFDPO 1x1ml · 15mg SFDPO 1x1ml · 20mg SFDPO 1x1ml · 25mg SFDPO 1x1ml
Health Canada comments